Evidence map›Paper›PMID 39062556›Full record

ArticleBiomolecules2024

Long- and Short-Term Glucosphingosine (lyso-Gb1) Dynamics in Gaucher Patients Undergoing Enzyme Replacement Therapy.

Pawel Dubiela, Paulina Szymanska-Rozek, Piotr Hasinski, Patryk Lipinski, Grazina Kleinotiene, Dorota Giersz, Anna Tylki-Szymanska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Obstacles to Early Diagnosis of Gaucher Disease.Therapeutics and clinical risk management · 2025
    Review
  4. Effects ofInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pawel DubielaDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0001-8537-4404
Paulina Szymanska-RozekFaculty of Mathematics, Informatics and Mechanics, University of Warsaw, 00-927 Warsaw, Poland.
Piotr HasinskiDepartment of Internal Medicine and Gastroenterology, Municipal Hospital, 43-100 Tychy, Poland.ORCID 0000-0001-9667-5042
Patryk LipinskiInstitute of Clinical Sciences, Maria Skłodowska-Curie Medical Academy, 00-136 Warsaw, Poland.ORCID 0000-0002-1849-8375
Grazina KleinotieneFaculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Dorota GierszDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0002-9298-0688
Anna Tylki-SzymanskaDepartment of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-736 Warsaw, Poland.ORCID 0000-0002-8935-1768

Funding

The Children's Memorial Health Institute and Medical Research Agency 2021/ABM/02-00014-00
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Enzyme Replacement TherapyGaucher DiseaseGlucosylceramidaseAdolescentAdultAgedBiomarkersChildChild, PreschoolFemaleHumansMaleMiddle AgedPsychosineYoung AdultBiomarkersGlucosylceramidasePsychosinebiomarkerenzyme replacement therapyGaucher diseaseglucosylsphingosinelyso-Gb1

Identifiers

PMID39062556
PMCPMC11275231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.